Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Acquisitions: -$147M in FY2025, down 96.3% from a year earlier.
Latest, FY2025
-147
Period ended Dec 31, 2025
Change on a year earlier
-96.3%
-4,018 in FY2024
History
3 years
Since FY2023
Sources
1
Novartis 20-F (0001114448-26-000004, filed 2026-02-04)
Where the FY2025 figure comes from
Source: Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Reported in Postgres DB + Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Acquisitions ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -147 | -96.3% | Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | -4,018 | +12.8% | Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗ |
| FY2023 | Dec 31, 2023 | -3,561 | – | Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗ |
Cite this data
StockData. (2026). Novartis Acquisitions ($M), annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-cf-acquisitions
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.